Literature DB >> 25194005

IgD heavy-chain deposition disease: detection by laser microdissection and mass spectrometry.

Virginie Royal1, Patrick Quint2, Martine Leblanc3, Richard LeBlanc4, Garrett F Duncanson2, Robert L Perrizo2, Fernando C Fervenza5, Paul Kurtin2, Sanjeev Sethi6.   

Abstract

Monoclonal Ig deposition disease (MIDD) is a rare complication of monoclonal gammopathy characterized by deposition of monoclonal Ig light chains and/or heavy chains along the glomerular and tubular basement membranes. Here, we describe a unique case of IgD deposition disease. IgD deposition is difficult to diagnose, because routine immunofluorescence does not detect IgD. A 77-year-old man presented with proteinuria and renal failure, and kidney biopsy analysis showed a nodular sclerosing GN with extensive focal global glomerulosclerosis, tubular atrophy, and interstitial fibrosis. Immunofluorescence was negative for Ig deposits, although electron microscopy showed deposits in the glomeruli and along tubular basement membranes. Laser microdissection of glomeruli and mass spectrometry of extracted peptides showed a large spectra number for IgD, and immunohistochemistry showed intense glomerular and tubular staining for IgD. Together, these findings are consistent with IgD deposition disease. Bone marrow biopsy analysis showed 5% plasma cells, which stained for IgD. The patient was treated with bortezomib and dexamethasone, which resulted in improvement of hematologic parameters but no improvement of renal function. The diagnosis of IgD deposition disease underscores the value of laser microdissection and mass spectrometry in further evaluating renal biopsies when routine assessment fails to reach an accurate diagnosis.
Copyright © 2015 by the American Society of Nephrology.

Entities:  

Keywords:  immunology and pathology; multiple myeloma; renal pathology

Mesh:

Substances:

Year:  2014        PMID: 25194005      PMCID: PMC4378111          DOI: 10.1681/ASN.2014050481

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  33 in total

1.  Two types of glomerular lesion in non-amyloid immunoglobulin deposition disease: a case report of IgD-lambda myeloma.

Authors:  Y Kubo; T Morita; Y Koda; Y Hirasawa
Journal:  Clin Nephrol       Date:  1990-06       Impact factor: 0.975

Review 2.  Heavy chain deposition disease: the disease spectrum.

Authors:  N Kambham; G S Markowitz; G B Appel; M J Kleiner; P Aucouturier; V D D'agati
Journal:  Am J Kidney Dis       Date:  1999-05       Impact factor: 8.860

3.  Prevalence of monoclonal gammopathy of undetermined significance.

Authors:  Robert A Kyle; Terry M Therneau; S Vincent Rajkumar; Dirk R Larson; Matthew F Plevak; Janice R Offord; Angela Dispenzieri; Jerry A Katzmann; L Joseph Melton
Journal:  N Engl J Med       Date:  2006-03-30       Impact factor: 91.245

4.  Incorporation of SP-40,40 into the soluble membrane attack complex (SMAC, SC5b-9) of complement.

Authors:  N H Choi; Y Nakano; T Tobe; T Mazda; M Tomita
Journal:  Int Immunol       Date:  1990       Impact factor: 4.823

Review 5.  Monoclonal gammopathy of undetermined significance, Waldenström macroglobulinemia, AL amyloidosis, and related plasma cell disorders: diagnosis and treatment.

Authors:  S Vincent Rajkumar; Angela Dispenzieri; Robert A Kyle
Journal:  Mayo Clin Proc       Date:  2006-05       Impact factor: 7.616

6.  Nodular glomerulosclerosis with deposition of monoclonal immunoglobulin heavy chains lacking C(H)1.

Authors:  B Moulin; S Deret; X Mariette; O Kourilsky; H Imai; L Dupouet; L Marcellin; I Kolb; P Aucouturier; J C Brouet; P M Ronco; B Mougenot
Journal:  J Am Soc Nephrol       Date:  1999-03       Impact factor: 10.121

7.  Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathway.

Authors:  Sanjeev Sethi; Jeffrey D Gamez; Julie A Vrana; Jason D Theis; H Robert Bergen; Peter F Zipfel; Ahmet Dogan; Richard J H Smith
Journal:  Kidney Int       Date:  2009-01-28       Impact factor: 10.612

Review 8.  Nodular glomerulosclerosis in the nondiabetic smoker.

Authors:  Samih H Nasr; Vivette D D'Agati
Journal:  J Am Soc Nephrol       Date:  2007-06-13       Impact factor: 10.121

Review 9.  Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma.

Authors:  R A Kyle; S V Rajkumar
Journal:  Leukemia       Date:  2008-10-30       Impact factor: 11.528

10.  Renal lesions associated with plasma cell dyscrasias: practical approach to diagnosis, new concepts, and challenges.

Authors:  Guillermo A Herrera
Journal:  Arch Pathol Lab Med       Date:  2009-02       Impact factor: 5.534

View more
  7 in total

Review 1.  The Complexity and Heterogeneity of Monoclonal Immunoglobulin-Associated Renal Diseases.

Authors:  Sanjeev Sethi; S Vincent Rajkumar; Vivette D D'Agati
Journal:  J Am Soc Nephrol       Date:  2018-04-27       Impact factor: 10.121

2.  Characterization of glomerular extracellular matrix by proteomic analysis of laser-captured microdissected glomeruli.

Authors:  Liliane Hobeika; Michelle T Barati; Dawn J Caster; Kenneth R McLeish; Michael L Merchant
Journal:  Kidney Int       Date:  2016-12-15       Impact factor: 10.612

3.  Coexistence of Light- and Heavy-Chain Deposition Disease and Immunotactoid Glomerulopathy in a Patient with Multiple Myeloma: A Case Report.

Authors:  Yaoxian Liang; Bao Dong; Lei Jiang; Xin Li; Chunying Shao; Yu Yan; Li Zuo
Journal:  Case Rep Nephrol Dial       Date:  2022-03-21

Review 4.  Monoclonal gammopathy of renal significance: Diagnostic workup.

Authors:  Sofia O Correia; Sofia Santos; Jorge Malheiro; António Cabrita; La Salete Martins; Josefina Santos
Journal:  World J Nephrol       Date:  2017-03-06

5.  [Advances in diagnosis and treatment of monoclonal immunoglobulin deposit disease].

Authors:  J T Zhao; W L Ye; J L Zhuang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-01-14

6.  The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group.

Authors:  Nelson Leung; Frank Bridoux; Vecihi Batuman; Aristeidis Chaidos; Paul Cockwell; Vivette D D'Agati; Angela Dispenzieri; Fernando C Fervenza; Jean-Paul Fermand; Simon Gibbs; Julian D Gillmore; Guillermo A Herrera; Arnaud Jaccard; Dragan Jevremovic; Efstathios Kastritis; Vishal Kukreti; Robert A Kyle; Helen J Lachmann; Christopher P Larsen; Heinz Ludwig; Glen S Markowitz; Giampaolo Merlini; Peter Mollee; Maria M Picken; Vincent S Rajkumar; Virginie Royal; Paul W Sanders; Sanjeev Sethi; Christopher P Venner; Peter M Voorhees; Ashutosh D Wechalekar; Brendan M Weiss; Samih H Nasr
Journal:  Nat Rev Nephrol       Date:  2019-01       Impact factor: 28.314

7.  Light chain deposition disease involving kidney and liver in a patient with IgD myeloma.

Authors:  Takafumi Tsushima; Tomo Suzuki; Toshiki Terao; Daisuke Miura; Kentaro Narita; Masami Takeuchi; Akira Shimuzu; Kosei Matsue
Journal:  BMC Nephrol       Date:  2021-01-23       Impact factor: 2.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.